Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "alexion pharmaceuticals"

X-Chem achieves milestone in drug discovery collaboration with...

X-Chem has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, triggering a payment to X-Chem. X-Chem met this milestone under a partnership established with Alexion in December 2014. Under the terms of the ... Pharmaceutical Business Review, 1 month ago
[x]  

13 images for alexion pharmaceuticals

American Banking News, 1 week ago
Octafinance, 2 weeks ago
Jutia Group, 3 weeks ago
Octafinance, 3 weeks ago
Nasdaq, 5 days ago
Nasdaq, 2 weeks ago
Nasdaq, 3 weeks ago
Nasdaq, 3 weeks ago
Nasdaq, 3 weeks ago
ACQ Magazine, 3 weeks ago
Nasdaq

Alexion Pharmaceuticals (ALXN) David L. Hallal on Q1 2016 Results - Earnings Call Transcript

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Q1 2016 Earnings Call April 28, 2016 10:00 am ET Executives Elena H. Ridloff - Vice President, Investor Relations David L. Hallal - Chief Executive Officer & Director Vikas Sinha - ...
 Seeking Alpha1 month ago Alexion Pharmaceuticals (ALXN) Q1 2016 Results - Earnings Call Webcast  Seeking Alpha1 month ago Alexion Pharmaceuticals Q1 16 Earnings Conference Call At 10:00 AM ET  Nasdaq1 month ago ChromaDex's (CDXC) CEO Frank Jaksch on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha1 week ago

Alexion misses Street 1Q forecasts

Alexion Pharmaceuticals misses 1Q earnings and revenue expectations 8
 Yahoo! Finance1 month ago Alexion Pharmaceuticals misses by $0.02, misses on revenue  Seeking Alpha1 month ago
Nasdaq

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Impact Score At 90

Alpha One explored various online articles released on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) , and it set a daily sentiment score of 0 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring ...
 Markets Daily1 day ago Baron Funds Comments on Alexion Pharmaceuticals  Nasdaq5 days ago OLD National Bancorp IN Acquires 891 Shares of Alexion Pharmaceuticals, Inc. (ALXN)  WKRB News5 days ago Texas Permanent School Fund Sells 2,132 Shares of Alexion Pharmaceuticals, Inc. (ALXN)  WKRB News5 days ago
[x]  

How Wall Street Feels about Alexion's 1Q16 Earnings

Alexion Disappointed in 1Q16, but What's that Mean for Investors? Revenue in 1Q16 Alexion Pharmaceuticals (ALXN),a biotechnology company based in Cheshire, Connecticut, reported its 1Q16 earnings on April 29, 2016. Alexion reported sales amounting ...
 Yahoo! Finance UK and Ireland3 weeks ago
[x]  

Strong On High Volume: Alexion Pharmaceuticals (ALXN)

Trade-Ideas LLC identified Alexion Pharmaceuticals ( ALXN) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Alexion Pharmaceuticals as such a stock due to the following factors: ...
 TheStreet.com3 weeks ago

On Tap for Analysts: Boston Scientific, Ford, Western Digital

RATINGS CHANGES Alexion Pharmaceuticals (ALXN - Get Report) was upgraded to outperform at BMO Capital. $168 price target. The post-earnings selloff has created a buying opportunity, BMO said. Boston Scientific (BSX - Get Report) was upgraded to buy ...
 TheStreet.com4 weeks ago

Alexion Posts Higher 1Q Revenue As Profit Declines [The Hartford Courant]

April 28--Alexion Pharmaceuticals Inc. reported Thursday a nearly 17 percent increase in first quarter revenue, though profit fell as the drug maker cited economic and market weaknesses in Latin America and a strong dollar that makes U.S. exports ...
 Bloomberg1 month ago

Alexion reports Q1 results, updates guidance

Alexion Pharmaceuticals ( ALXN -4.2%) Q1 results : Revenues: $701M (+16.8%); R&D Expense: $176.3M (-20.3%); SG&A: $232.6M (+24.3%); Operating Income: $165.8M (+59.9%); Net Income: $92.2M (+1.0%); EPS: $0.41 (-8.9%); Non-GAAP EPS: $1.11 (-13.3%); ...
 Seeking Alpha1 month ago

Pre-Market Laggard: Alexion Pharmaceuticals (ALXN)

Trade-Ideas LLC identified Alexion Pharmaceuticals ( ALXN) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Alexion Pharmaceuticals as such a stock due to the following factors: ALXN has an ...
 TheStreet.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less